ArticleCureus2026

Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report.

Shohei Otsuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.